You Searched For "zydus lifescience" and got 15 results
Sort By:
Stock market opening: Nifty, Sensex open the day in red, Dr. Reddy, Divis Labs take lead in early trade
Divis Labs, Dr. Reddy, Larsen and Toubro, Hindustan Unilever, and Nestle India gained an early edge…
Zydus Q4 net profit surges 4-fold to ₹1,182 cr; revenue at ₹5,534 cr
Revenue from operations rose to Rs 5,534 crore in the period under review from Rs 5,011 crore i…
PTI
Zydus Lifesciences acquires UK-based LiqMeds Group for GBP 68 million
LiqMeds Group of companies specialises in the development, manufacturing and supply of oral liq…
PTI
Zydus Lifesciences Q1 2023-24 profit up 2-fold at Rs 1,087 cr
Revenue from operations during the quarter under review stood at Rs 5,139.6 crore as against Rs…
PTI
Cadila Healthcare trumps peers, in talks to acquire Claris Lifesciences for whooping Rs 3,400 crore
As per sources, the last minutes negotiations are underway between the both companies, including ta…
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
US outlook improves for Indian pharma but domestic market under the cloud
The Indian pharma sector has gone through many ups and downs in the last few years – like falling f…
Sensex, Nifty50 surge in morning trade led by banking and metal stocks
India’s benchmark indices Sensex and Nifty50 are likely to open in the green on Thursday amid posit…
Sensex, Nifty50 edge lower in morning trade, dragged by Infosys, Wipro and realty stocks
India’s equity markets are likely to open in the red on Wednesday amid negative cues in global mark…
Mankind Pharma, PNB among stocks to become largecap from midcap; mutibagger Rail Vikas Nigam to turn midcap from smallcap
The Association of Mutual Funds in India (AMFI) releases reclassification of largecap, midcap an…
These are the companies manufacturing COVID-19 drug Remdesivir in India
The agreements allow these companies to manufacture remdesivir for distribution in 127 count…
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …